AMERICAN SOCIETY OF PHARMACOVIGILANCE: FDA Becomes a Member of STRIPE, New Collaborative Community to Help Advance Pharmacogenomics (PGx) into Clinical Practice
The American Society of Pharmacovigilance (ASP) announced that the Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) Initiative has developed a collaborative community with participation by the U.S. Food and Drug Administration's (FDA) Center for Devices and Radiological Health (CDRH).